India’s COVID-19 Catastrophe: Cause, Effect & Future Trends

The COVID crisis in India shows no sign of abating. country 1.4 billion has passed 30.5 million COVID-19 infections and over 402,000 deaths. Even government figures are likely underestimated due to problems with testing reporting the country. Reasonable estimates under lack put these at three times higher. new cases deaths predicted rise by September 2021. situation is bad main cities, but also that it worse poorer rural areas where healthcare resources made those populations most vulnerable disease. There an urgent need for rapid tests quantification infectiousness triage patients. In traumatised India, saving lives become highest priority be achieved vaccinating 70 per cent adult population. Over 200 population have been vaccinated. India’s monthly vaccine manufacturing capacity about 60 - 65 doses against final requirement 1.45 cover adults. though second surge on a decline states, mucormycosis continues public health concern. 41,000 reported during wave. Daily increase Delta plus variant should alert Policy-makers. It very high transmissibility. Genomic & surveillance mutations limit fresh twist pandemic necessity. Only few drugs emerged as approved treatments. Where we drug treatment? 30 USD spent development because market. Very little research discovery. not any significant antibiotic molecule last two decades. Politics played play big part spread virus needs global approach. Tiding requires detailed preparation multiple levels State. New ways prevent, detect, track treat SARS-CoV-2 crucial keeping view more-transmissible viral mutants like plus.